(Q27074366)

GNF-PF-254 (English)

3 October 2016

C₃₁H₂₇N₄S⁺

1 reference

based on heuristic

inferred from SMILES

canonical SMILES

CC[N+]1=C(N(C2=C1C=C(C=C2)C3=NC4=CC=CC=C4S3)C5=CC=CC=C5)C=CN(C)C6=CC=CC=C6

1 reference

GNF-PF-254 (English)

3 October 2016

CC[N+]1=C(N(C2=C1C=C(C=C2)C3=NC4=CC=CC=C4S3)C5=CC=CC=C5)/C=C/N(C)C6=CC=CC=C6

1 reference

InChI=1S/C31H27N4S/c1-3-34-28-22-23(31-32-26-16-10-11-17-29(26)36-31)18-19-27(28)35(25-14-8-5-9-15-25)30(34)20-21-33(2)24-12-6-4-7-13-24/h4-22H,3H2,1-2H3/q+1

GNF-PF-254 (English)

retrieved

3 October 2016

Identifiers

InChI

1 reference

OTHITMYLBRCVIT-UHFFFAOYSA-N

GNF-PF-254 (English)

3 October 2016

2 references

GNF-PF-254 (English)

3 October 2016

ChEBI release 2020-09-01

1 reference

5-(1,3-Benzothiazol-2-yl)-3-ethyl-2-{(E)-2-[methyl(phenyl)amino]vinyl}-1-phenyl-1H-benzimidazol-3-ium (English)

3 October 2016

1 reference

GNF-PF-254 (English)

3 October 2016

mapping relation type

1 reference

N-[2-[5-(1,3-benzothiazol-2-yl)-3-ethyl-1-phenyl-2-benzimidazol-3-iumyl]ethenyl]-N-methylaniline (English)

3 October 2016

1 reference

Guide to Pharmacology Ligand ID

CHEMBL1186409 (English)

3 October 2016

1 reference

5919

1 reference

stated in

IUPHAR/BPS Guide to PHARMACOLOGY

Guide to Pharmacology Ligand ID

5919